Software that automatically computes six embedded validity indicators from tests already administered in an adult ADHD evaluation (Stroop, Trail Making, Verbal Fluency, WAIS-IV subtests) and flags the file when any two fail — a ≥90%-specificity screen for non-credible performance that adds zero extra testing time.
The PESTEL analysis reveals a strong product-market fit driven by the surge in telehealth ADHD assessments and a critical need for efficiency in validity screening. While technological and economic drivers are highly positive, the primary risks are legal and social, specifically regarding the potential for false positives to impact patient care and the regulatory scrutiny of automated diagnostic aids.
Political2
Economic3
Social3
Technological3
Environmental2
Legal3
The viability of a clinical diagnostic tool depends heavily on healthcare regulations, medical ethics, and the legal standards for ADHD diagnosis. · Generated 2026-10-12 by cavi/gemma4-31b-it-awq-4bit-32kAI-generated